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Summary 
Many public policies and individual actions have consequences for population health. To 
understand if a (costly) policy undertaken to improve population health is a wise use of 
resources, analysts can use economic evaluation methods to assess the costs and benefits. To be 
able to do this, it is necessary that the costs and benefits are evaluated using the same metric, and 
for convenience a monetary measure is commonly used. It is well established that money 
measures of a reduction in health risks can be theoretically derived using the willingness to pay 
concept. However, since a market price for health risks is not available, analysts have to rely on 
analytical techniques to estimate the willingness to pay using revealed or stated preference 
methods. Revealed preference methods infer willingness to pay based on individuals’ actual 
behavior in markets related to health risks and include approaches such as hedonic pricing 
techniques. Stated preference methods use a hypothetical market scenario where respondents 
make trade-offs between wealth and health risks. Using, for example, a random-utility 
framework, it is possible to directly estimate individuals’ willingness to pay by analyzing the 
trade-offs individuals’ make in the hypothetical scenario. Stated preference methods are 
commonly applied using contingent valuation or discrete choice experiment techniques. Despite 
criticism and shortcomings of both revealed and stated preference methods, substantial progress 
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has been made over the last couple of decades in using both approaches to estimate the 
willingness to pay for health risk reductions. 
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Does it make economic sense to implement human papillomavirus (HPV) vaccination in national 
child vaccination programs? What are the economic consequences of stricter vehicle emission 
standards that improve air quality and therefore reduces cardiovascular mortality and morbidity 
risks?  
 Public policy commonly addresses questions where the trade-offs involve comparing 
economic costs to the health benefits associated with investments and regulations. The input 
from economic analyses on the merits of such regulations are typically based on cost-
effectiveness analysis (CEA) or cost-benefit analysis (CBA). In CEA, the health risks are not 
evaluated using monetary values and therefore these analyses cannot be (directly) used to assess 
the economic welfare effects of public policies.i  The aim of a CBA is to assign monetary values 
to the predicted benefits and costs using a societal perspective: identifying, measuring and 
valuing the consequences for individuals, firms, and the public sector. If the net present value 
(NPV) is positive, i.e. the present value of all benefits outweighs the present value of all costs, 
the regulation is said to increase social welfare (The “Hicks-Kaldor” criterion).      
 Cost-benefit analyses of policy proposals have increased in use and importance over 
time. In the US, the use of CBA to inform policy makers on the consequences of policy 
proposals has been explicitly encouraged since the early 1980s. For proposals with an economic 
impact over 100 million US dollars, federal agencies are required to carry out analyses using 
CBA (Obama 2011). Several federal agencies, such as the Department of Transport and the 
Environmental Protection Agency, have also published specific guidelines on how to implement 
CBA in their specific domain, including recommended monetary values of e.g. mortality and 
morbidity health risks (EPA 2010, DoT 2016). In Europe, many national agencies also demand 
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and carry out CBA of major regulations and investments (Andersson 2018). The UK government 
outlines principles of CBA in the “Green Book”, which is introduced by stating that each new 
policy, program or project must be assessed in terms of: “Are there better ways to achieve this 
objective?” and “Are there better uses for these resources?” (HM TREASURY 2003). At the 
level of the European Union, the European Commission (2014) has also developed a framework 
for how new regulations and investments can be evaluated using CBA. 
 To be able to carry out CBA of policies that involve improved (or worsened) population 
health it is necessary to value the predicted health changes in a monetary metric, e.g. US dollars, 
Chinese Yuan, Euros, etc. Considering that health risks are not directly traded in markets, the 
valuation of health risks is commonly one of the main challenges in CBA. The appropriate 
economic value of a health change is the willingness to pay (WTP) or the willingness to accept 
(WTA) for the health change. The WTP is defined as the maximum price a person is willing to 
give up to receive a specific good/service. The WTA is defined as the minimum amount a person 
is willing to accept to refrain from a good or service, or the compensation for an increase in a 
disamenity (e.g. health risk). 
 For public policy regulations and investments, the changes in average individual health 
risks are typically very small and the valuation exercise thus concerns individuals’ WTP for a 
very small change in the health risk (e.g. the mortality risk). The total economic value of such a 
policy is then the population aggregate of each individual’s WTP. Most research efforts have 
been devoted to WTP estimates of changes in mortality risk, which may be due to the importance 
of mortality risk consequences of many public policies as well as the fact that death is a 
relatively easy concept to define compared to many morbidity risks that are less objective. The 
economic term used for the trade-off between mortality risk and wealth is (commonly) the value 
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of a statistical life (VSL). The term “statistical” highlights the fact that we are considering 
unidentified, rather than identified, lives.  
 To illustrate VSL we assume a population of 10,000 individuals where the baseline 
mortality risk (e.g. cancer risk) is 5/10,000, i.e. each year 5 persons in the population will die of 
cancer. Now imagine that a preventive treatment (e.g. a screening program) is estimated to 
reduce the annual mortality risk to 4/10,000, i.e. 1 person less would die each year, but it is not 
identified (ex-ante) who this person will be, and that everyone will benefit from the same risk 
reduction. We estimate the mean WTP for the screening program to $100. This implies that the 
population WTP for the program and thus the VSL is $100 10,000 = $1 million, which we can 
interpret such that the population is in aggregate willing to pay $1 million to reduce deaths by 1 
person (“1 statistical life”). 
 Lacking market prices for WTP estimates of mortality (and morbidity) risks, economists 
have developed several approaches to derive monetary values using what broadly can be 
classified as revealed- (RP) and stated-preferences (SP) approaches. RP approaches rely on 
observed market behavior, and the most common RP approach has been to assess the wage 
premium necessary to compensate for jobs with higher mortality and/or morbidity risks. SP 
studies are based on surveys and experiments where individuals are asked to make hypothetical 
choices between different programs or investments with varying costs and health risks. 
 The rest of this study will explore in more detail the theoretical foundations and empirical 
methods to estimate the WTP for small changes in health risks. The following sections are 
structured as follows. Section 2 covers the general theoretical background to the valuation of 
mortality risks, which can also be extended and applied to value other types of health risks. 
Section 3 describes the empirical approaches in more detail, with a particular focus on hedonic 
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price regressions as the main RP approach used in valuation of health risks and the two main SP 
approaches of discrete choice experiments (DCE) and contingent valuation method (CVM) 
studies. In section 4 we present some applications in the form of empirical studies that have used 
hedonic pricing, DCE and CVM to estimate the WTP for small changes in mortality and/or 
morbidity risks. In section 5 we conclude and also discuss some of the main challenges and 
criticisms regarding the empirical methods to derive values of health risks. We conclude by 
highlighting some of our views on the most fundamental knowledge gaps in order to increase our 




As explained, the WTP concept is considered the appropriate approach to elicit monetary values. 
However, at the time of  Schelling (1968)’s discussion of the use of a WTP approach the human 
capital (HC) approach dominated as a means to estimate the social value of reducing mortality 
risk. The underlying assumption of the HC approach is that the market goods and services 
produced by an individual during his lifetime reflect his value to society (Mishan 1982). It is 
calculated as the expected future earnings, and hence does not consider individual preferences to 
reduce the risk of death. Under some (plausible) assumptions and restrictions it has been shown 
that the HC can serve as a lower bound for the VSL (Bergstrom 1982, Rosen 1988), but it is in 
general considered a poor proxy for a preference based, i.e. WTP, measure of individual risk 
preferences (e.g. Freeman et al. 2014). 
 We will in this section focus on the elicitation of preferences to reduce the risk of death. 
The models described below can be generalized to also cover morbidity risks (Andersson et al. 
 7 
2015), but since mortality risk is a clearly defined outcome using it avoids having to address 
heterogeneity issues related to morbidity risksii. As described the VSL is the aggregated 
monetary value of avoiding one statistical death in society. It is the population mean of the 
marginal WTP to reduce mortality risk and should not be interpreted as the value of an identified 
life. However, since the VSL contains the word “life” the concept leads to confusion and 
misunderstandings and it has been suggested to change it to something more neutral (e.g., 
Cameron 2010). While it is being discussed whether to change it, VSL is still the terminology 
used, and hence we also use it in this study. 
 In the following sub-section we will present the standard one-period model for VSL 
together with some predictions from the model and the literature. We will then describe a 
multiperiod model. The extension from the one- to the multiperiod model is of high relevance for 
examining health risks since it allows us to examine how individuals’ WTP may vary over the 
life-cycle, but also since many health risks are characterized by an often substantial time interval 
between a change in exposure and the health effect. This is usually referred to as latency and its 
effect on WTP can be examined in the multiperiod model. 
 
One-Period Model 
The VSL refers to the population mean of the marginal rate of substitution (MRS) between 
mortality risk and wealth, under the assumption that the individual MRS and the personal change 
in risk is uncorrelated (see e.g. Jones-Lee 2003). The theoretical model assumes that individuals 
maximize their utility in a state-dependent expected utility framework (Dreze 1962, Jones-Lee 
1974, Rosen 1988). Let p define survival probability and us(w) the state-dependent utilities of 
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wealth (w), where the states are either staying alive (s=a) or dead (s=d), and individuals are 
assumed to maximize, 
)w(u)p1()w(pu)p,w(EU da −+= . (2.1) 
Following the standard assumptions in the literature we assume that the utility functions are 
twice differentiable, that utility of wealth is higher if alive than dead, that marginal utility of 
wealth is non-negative and higher if alive than dead, and that individuals are weakly risk averse 
to financial risks, i.e., 
( ) ( ),  ( ) ( ) 0a d a du w u w u w u w′ ′> > ≥ and ( ) 0su w′′ ≤ . (2.2) 
Hence, at any wealth level both the utility and the marginal utility are higher if alive than dead 
and given these assumptions the indifference curves over wealth and survival probability are, as 
illustrated in Figure 1, decreasing and strictly convex. 
 Using Eq. (2.1) we can derive the compensating and equivalent surplus, i.e. the WTP and 
WTA, for a change in the mortality risk ∆p≡ε (Freeman et al. 2014). Let EU0 be defined by Eq. 
(2.1) and C(ε) denote the WTP for the risk reduction ε, then C(ε) is given by, 
( ) ( ) ( ) 0da EU)(Cwu)p1()(Cwup =−−−+−+ εεεε , (2.3) 
and similarly if we let P(ε) denote the WTA for the risk increase ε, then P(ε) is given by, 
( ) ( ) ( ) 0da EU)(Pwu)p1()(Pwup =++−++− εεεε . (2.4) 
As evident from Eqs. (2.3) and (2.4), and illustrated in Figure 1, WTP and WTA will depend on 
the size of ε. The larger the change in the mortality risk, the larger is the WTP or WTA 
depending on whether it is an increase or decrease in ε. However, when eliciting WTP and WTA 
for changes in mortality risks the size of ε will be small. We therefore expect WTP and WTA to 
be nearly equal and that they are near-proportional to ε (Hammitt 2000).  
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Figure 1. The value of a statistical life 
 
Source: Lectures notes, Henrik Andersson, Toulouse School of Economics, inspired by lectures notes by 
James Hammitt, Harvard University. 
 
 The VSL measures the WTP or WTA for an infinite small change in risk, and can be 
obtained by taking the limit of WTP or WTA when ε≅0. That is, as explained above it is the 
MRS between wealth and mortality risk and is defined as follows, 
( ) ( )












It is derived by totally differentiating Eq. (2.1) and keeping utility constant. Hence, it is the ratio 
between the utility difference and expected marginal utility and given by the assumptions in (2.2) 
VSL is always strictly positive. 
 Equation (2.5) can be empirically estimated as will be described and shown in sections 3 
and 4. However, in empirical applications the risk reduction may be small but finite. This could 
be the case in surveys where it does not make sense to ask respondents about a truly marginal 
risk change, or in studies looking at discrete decisions in markets. In those cases, the VSL is 






= . (2.6) 
Equation (2.6) suggests that the WTP is proportional to the change in risk. But, as explained, the 
true relationship between WTP and the size of ∆p is only near-proportional, which is a 
necessary, but not sufficient, condition for WTP to be a valid measure of individuals’ preferences 
(Hammitt 2000).  
 
The Wealth and the Dead-Anyway Effect 
For the empirical applications of the theoretical framework described in the previous section 
predictions are important to test the construct validity of the findings. Two standard predictions 
are the wealth and dead-anyway effect. First, to examine how wealth influences WTP is central 
to test the validity of preference estimates, not only for health risk, but also for other non-market 
goods (Arrow et al. 1993). The wealth effect in this scenario describes how VSL increases with 
wealth (Weinstein et al. 1980). The intuition is clear, i.e. that wealthier individuals (everything 
else equal) can pay more for a good, and in this scenario it can be broken down to: (i) the 
numerator in Eq. (2.5) increases in wealth, and (ii) the expected marginal utility in the 
denominator decreases in wealth. Both effects are assured by the assumptions in (2.2) and the 
results state that wealthier individuals have more to lose and that their utility cost of spending is 
smaller. 
 Second, the dead-anyway effect (Pratt and Zeckhauser 1996) suggests that WTP 
increases with the baseline risk, i.e. decreases with the survival probability (p). Since p only 
shows up in the denominator of Eq. (2.5) the dead-anyway effect does not depend on the utility 
difference in the numerator. Instead the effect is driven by the fact that the size of the 
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denominator increases when p increases since u’a>u’d. The intuition is that a person at a high 
risk has little incentives to limit his spending on increasing his survival probabilities. 
 
The Model and Selected Predictions 
The two predictions described in the previous sections, and the one provided before on WTP and 
WTA being sensitive to the size of the mortality risk reduction, can be considered the basic 
predictions of the standard one-period VSL model. The model has also been used to provide 
several other predictions that are useful for understanding and testing the validity of empirical 
findings. For instance, the survival probability presented so far has been the overall chance of 
survival. However, individuals face many different types of risks, and individuals’ WTP to 
reduce one risk may be influenced by the other risks that they face. These can be referred to as 
background risks and depending on whether these background risks are independent (Eeckhoudt 
and Hammitt 2001) or additive (Andersson 2008) to the specific risk it can be shown that VSL 
can either decrease or increase. Moreover, it has been shown that “Although aversion to financial 
risk increases VSL in definable cases, under many plausible assumptions the relationship 
between risk aversion and VSL is ambiguous.” (Eeckhoudt and Hammitt 2004, p. 13), and that 
VSL increases with ambiguity aversion (Treich 2010).  
 Another example is the effect on health status on the VSL. Assuming that utility of 
wealth is higher in good than in bad health and that the marginal utility of wealth is increasing in 
health status, then both the numerator and denominator of Eq. (2.5) will increase, and hence, the 
effect on VSL will be ambiguous (Hammitt 2002, Strand 2006). We will not in this paper go into 
any details about these predictions. Instead we refer to the above provided references for readers 




The model above is a single-period model. We here extend our model to a multiperiod model. 
The latter may be considered to be more realistic since individuals do have preferences for how 
the survival probability and consumption opportunities are distributed over their length of life. 
Moreover, it also allows for the examination of how age and latency affect individual WTP to 
reduce mortality risk. 
 The theoretical foundation is the life-cycle model in which individuals are assumed to 
maximize their expected value of the utility of consumption (see e.g. Yaari 1965, Johansson 
2002). Let τ, u(ct), i, and qτ,t=pτ…pt-1, denote the point of reference, the utility of consumption at 
time t, the utility discount rate, and the probability at τ of surviving to t. The individual’s 
expected utility is then given by,  










ττ  (2.7) 
To simplify the description of the multi-period model we follow Hammitt and Liu (2004) and 
illustrate it with a two period model (assuming for simplicity that the marginal utility of a 
bequest is equal to zero), 
),c(upp)c(upEU 2221111 +=  (2.8) 





+  (2.9) 
where, as above, p, u(c), and i are the survival probabilities (conditional on being alive at the 
beginning of each time period), utility of consumption, and the discount rate, with subscripts 1 
and 2 referring to the first and second time period. In a multi-period framework the VSL will 
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depend on the optimal consumption path and it can be shown that the optimization of 










 Let VSLj,k denote the marginal WTP of a survival probability that appears in k, but where 
the consumption is given up in j (i.e. the individual pays for the risk reduction in j). By totally 
differentiating Eq. (2.8) we obtain 















which is the corresponding expression for a risk reduction that appears today and where the 
individual gives up other consumption (wealth) today as in Eq. (2.5). However, many health 
risks are characterized by a time period between exposure and the health affect, referred to as a 
latency period. It is therefore of interest to also estimate the WTP for latent risks and the 















In Eqs. (2.10) and (2.11) we assume temporary risk reductions, i.e. the mortality risk is only 
reduced in a single time period, and we will use these two equations when we discuss predictions 
of age, latency, and multiperiod WTP in the next section. 
 
Age and Latency and Multiperiod WTP 
The relationship between age and preferences for health has gained a lot of attention and there is 
vast theoretical and empirical literature on the subject (see e.g. Huang et al. 2017). Intuitively it 
would make sense if WTP to reduce mortality risk would decline with age, since at older age 
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(everything else equal) an individual has less to gain from a reduction in the risk of dying. 
However, it has been shown that this expectation is not necessary true. The relationship between 
the WTP and age will depend on the optimal consumption path over the individual’s life-cycle, 
as shown by Eq. (2.10), which will depend on assumptions of the model. For instance, Shepard 
and Zeckhauser (1984) showed that in an economy where individuals can only optimize their 
consumption path by saving but not borrowing their VSL will have an inverted U-shape over 
their life, whereas in an economy where they can also borrow against future earnings their VSL 
declines monotonically with age. However, Johansson (2002) showed that the relationship is 
ambiguous since it depends on the assumptions of the model, i.e. it can in addition to the 
predictions above also be positive or independent. 
Above we introduced the concept of latency with Eq. (2.12) showing the marginal WTP 
for a latent risk reduction. Intuition will tell us that WTP for a current risk should exceed that of 
a latent risk, since an individual would benefit from an early risk reduction also in future time 
periods. However, as pointed out by Hammitt and Liu (2004) this intuition is misleading, and the 
WTP for a future risk reduction could also be equal or greater than the WTP for a current risk 
reduction. They show this by subtracting Eq. (2.12) from Eq. (2.11) which results in, 
















1,12,1 −<⇔>  (2.14) 
It is reasonable to assume that the survival probability will decline with age, and hence the right-
hand side of the element to the right of (2.14) will be positive. The condition on the left can be 
satisfied if the utility of consumption in the first period is sufficiently small compared to the one 
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in the second period, which “seems unlikely but cannot be ruled out” (Hammitt and Liu 2004, p. 
78). 
 So far we have discussed temporary risk reductions that last one time period. The 
multiperiod model can also be used to estimate the WTP for risk reductions that last several time 
periods or are permanent, since this WTP can be calculated as the summation of the WTP for 
future time periods with the risk reduction (Johannesson et al. 1997). This approach has also 
frequently been used in the empirical literature as a mean to make the change in risk more 
understandable by making the risk change larger. However, as shown by Andersson et al. (2013) 
this approach can introduce a non-negligible bias if the time period is too long, or if the discount 
rate is sufficiently high. 
 
Empirical Methods 
Since no easily available market prices exist for risk reduction policies researchers instead rely 
on what is usually referred to as non-market valuation techniques to estimate the WTP for such 
policies. As explained, these techniques can broadly be classified as either RP or SP methods. 
The former refers to methods that use individuals’ actual decisions in markets that are related to 
the good of interest, while the latter is based on individuals’ responses to hypothetical choice 
situations. In this section we review the main approaches used in the literature and refer to 






Revealed Preference Methods 
The most commonly used RP approach to estimate the WTP for risk reductions is the hedonic 
regression method (Rosen 1974), which is based on the notion that the price of a good is a 
function of its attributes. For example, the price of a house will depend on characteristics such as 
the number and size of the rooms, as well as its location (proximity to amenities, transport links 
etc.). The hedonic price function can then be written as:  
( )P P Q=  (3.1) 
 where P is the price of the good and 1 2( , , )kQ q q q= K  is a vector of attributes. Rosen showed 
that in a competitive market with utility maximizing individuals and profit maximising firms the 
marginal WTP (MWTP) for an attribute will equal its equilibrium implicit price. The implicit 
price of attribute kq  is given by the partial derivative of the hedonic price function with respect 










The hedonic wage method (Viscusi and Aldy 2003) is a variant of the hedonic regression 
technique which uses data on individuals’ job choices to infer the tradeoff workers are prepared 
to make between wages and risk. Holding other characteristics of the individuals and the job 
constant, the increase in wages associated with an increase in workplace risk can be interpreted 
as the compensation needed to keep the workers’ utility constant. The hedonic wage regression is 
typically specified along the following lines (Viscusi and Aldy 2003): 
α , (3.3) 
where wi is the wage rate of worker i, Xi is a vector of individual characteristics, Wi is a vector of 
job characteristics, pi is the probability of a fatal workplace accident, qi is the probability of a 
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non-fatal workplace accident and εi is an error term. The model can be extended by including 
interactions between pi and Xi, which allows the trade-off between wages and risk to vary across 
groups of workers depending on their characteristics, and interactions between qi and measures 
to compensate workers for non-fatal accidents. Based on the wage regression the marginal WTP 
for a reduction in risk can be derived as the effect of a unit increase in the probability of fatal 









If the model is linear the MWTP is simply given by γ1, although it is common in the literature to 
compare estimates using different functional forms (such as semi-log or log-linear), or use a 
Box-Cox regression that nests several functional forms. A more comprehensive overview of 
hedonic regression methods is given in Freeman et al. (2014). 
 The hedonic wage method has been used extensively to estimate the WTP for risk 
reductions, especially in the US (EPA 2016). There is also a substantial literature utilizing data 
from the housing market by recognizing that housing associated with differential health risks will 
be capitalized in the market price. Examples include studies assessing how house prices are 
affected by local cancer clusters associated with increased risks of pediatric leukemia (Davis 
2004) and how hazardous water pollution affects residential land prices (Leggett and Bocksstael 
2000). An example of another variant of the hedonic regression method is given in Andersson 
(2005), who studies the relationship between car prices and fatality risks. The observation that 
consumers can reduce health risks by purchasing products associated with lower risks (such as 
safer cars, or houses in less polluted areas) is the foundation for studies on averting behavior in 
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consumption, which also includes studies using alternatives to the hedonic regression method 
(see e.g. Blomquist 2004). 
         
Stated Preference Methods 
As the name suggests the SP approach is based on respondents’ stated choices in hypothetical 
market scenarios. There exists a wide range of different SP methods, but the most commonly 
used approaches to elicit individual WTP are the contingent valuation method (CVM) and 
discrete choice experiments (DCE) (Bateman et al. 2004). SP methods have been used to 
evaluate a wide range of health risks, such as contaminated water (Adamowicz et al. 2011), 
cancer risks (Hammitt and Haninger 2010), road mortality risks (Andersson et al. 2013), and fire 
and drowning risks (Carlsson et al. 2010). The advantage of the SP approach is that it offers 
flexibility in creating specific markets of interests and allows the analysts to control the decision 
alternatives. Johnston et al. (2017) provide best-practice recommendations for SP studies used to 
inform decision making. 
 
The Contingent Valuation Method  
The CVM presents a sample of survey participants with a hypothetical policy scenario that 
would reduce the risk of fatalities. The respondents are also presented with background 
information regarding the nature of the risk that the policy would reduce. The respondents are 
asked to either state their maximum WTP for the policy (open-ended CVM) or they are told how 
much they would have to pay if the policy was introduced (the “bid” in CVM terminology) and 
asked whether they are willing to pay this amount or not (closed-ended CVM).iii See Table 1 for 
an example of a closed-ended CVM question which is based on the application in Andersson et 
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al. (2016). In the influential review of the CVM method carried out by the National Oceanic and 
Atmospheric Administration (NOAA) panel (Arrow et al. 1993) the closed-ended approach was 
recommended, as it mimics a referendum in which respondents vote on whether a policy should 
be introduced in exchange for an increase in taxes. It is also similar to a market transaction in 
which consumers are presented with the price of a good and then decide whether or not to buy it.    
 Open-ended CVM data are straightforward to model using standard regression 
techniques, where the maximum WTP is specified as a function of individual characteristics. 
Closed-ended CVM data can be modelled using a latent variable framework, in which the latent 
(unobserved) WTP is specified as: 
*
i i iWTP Xα β ε′= + +  (3.5) 
where Xi is a vector of individual characteristics and εi is an error term which is typically 
assumed to be normally distributed with mean 0 and variance σ2. The probability that respondent 
i accepts a bid with value ri is then given by: 
*( ) ( ) ( ) 1 i ii i i i i i i i
r X
P WTP r P X r P r X
α βα β ε ε α β
σ
′− − ′ ′> = + + > = > − − = − Φ  
 (3.6) 
where Φ denotes the standard normal CDF. The α, β and σ parameters can be estimated by 
maximum likelihood in standard software using interval regression (e.g. intreg in Stata).iv  
 It is well established that the model specification can have a substantial impact on the 
estimated WTP, which indicates that analysts should conduct extensive sensitivity analyses using 
different specifications. It may also be advisable to estimate CVM data using distributional-free 
estimators such as the Turnbull estimator; see Haab and McConnel (2002) for an extensive 




Table 1. Example CVM question. 
Introductory text  
Campylobacter is a bacteria which can infect humans via food or water. Campylobacteriosis 
affects about 63000 people in Sweden each year, which means that 700 people are affected 
annually in a medium-sized city with 100,000 inhabitants. The symptoms of the disease vary 
from case to case, but somewhat simplified one can say that there are mild, intermediate and 
serious versions of the disease. It is not known which version of the disease one will get 
before being affected by campylobacteriosis. What we do know is that among those affected 
77 out of 100 get the mild version, 22 out of 100 the intermediate version, 1 out of 100 the 
serious version. In very rare cases affected individuals die from the disease (less than 5 per 
year in Sweden).       
CVM question 
Assume that a government authority is considering introducing a stricter water sanitation 
policy that will reduce the occurrence of campylobacter. Would you be willing to pay 2000 
SEK for a policy that would imply that 2 fewer persons will die in Sweden due to 
campylobacteriosis? 
 
Discrete Choice Experiments 
In DCEs the participants are presented with two or more hypothetical policies, and asked to 
choose their preferred policy or the status quo (not introducing either policy). As an example, we 
use a simple experiment with only two attributes; the number of fewer individuals who die when 
the policy is implemented and the cost of the policy (see Table 2). Respondents are asked to 
choose their preferred option between two hypothetical scenarios and the status-quo (the choice 
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set). In this simple form the DCE method shares many similarities with the closed-ended CVM 
method, but the advantage of DCEs is that further attributes of the alternatives can easily be 
accommodated in the experiment. For example, we could include an additional attribute 
representing the reduction in non-fatal cases of campylobacteriosis, which would allow us to 
investigate how individuals trade off reductions in fatal and non-fatal cases (Andersson et al. 
2016). The levels of the attributes presented to the participants in the experiment, i.e. the number 
of fatalities prevented and the cost of the policy, are varied according to an experimental design 
(Carlsson and Martinsson 2003). Typically, each respondent is presented with several 
hypothetical choice sets with different attribute levels. 
 Data from DCEs are typically analysed using a random utility model framework. The 
utility that respondent n derives from choosing alternative j in choice set t is given by: 
0 1 2njt njt njt njt njtU sq die costβ β β ε= + + +  (3.7) 
where 0β , 1β  and 2β  are coefficients to be estimated, njtsq  is a dummy variable for the status 
quo alternative, dienjt is the number of fewer individuals who die when the policy is 
implemented, costnjt is the cost of the policy and njtε  is a random error term which is assumed to 
be IID type I extreme value.  
 The MWTP for a reduction in risk equivalent to saving one life is given by the marginal 















Given the above assumptions the probability that respondent n chooses alternative j in choice set 



















The parameters in the multinomial logit (MNL) modelv can be estimated using maximum 
likelihood in standard software (e.g. asclogit in Stata). Lancsar et al. (2017) present a practical 
guide to modelling DCE data with examples using Stata and other software packages. 
 Other more advanced discrete choice methods which overcome the main limitations of 
the MNL model are commonly used in the DCE literature. In particular the assumption that 
respondents have the same preferences for changes in the attributes is usually regarded as being 
unrealistic. While this assumption can be relaxed by augmenting the MNL model with 
interactions between the attributes and respondent characteristics, the researcher does not 
typically observe all of the characteristics which are related to heterogeneity in preferences. The 
mixed logit model overcomes this limitation by allowing the parameters in the model to vary 
randomly. The vector of parameters β  is specified to have a particular distribution, ( | )f β θ , 
whose parameters θ  can be estimated. If the coefficients are normally distributed, for example, 
θ represents the mean and covariance of the distribution. The mixed logit probability that 
respondent n makes a particular sequence of choices is given by: 
0 1 2
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where njty  is a dummy variable which is equal to one if alternative j is chosen and zero 
otherwise, and 0 1 2( , , )β β β β= . In addition to allowing for preference heterogeneity the mixed 
logit model allows for the fact that respondents make multiple choices, as the individual 
preferences are assumed to remain constant over the choices made by the same individual. The 
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integral in Eq. (3.10) cannot be solved analytically, and it is therefore approximated using 
simulation methods. See Train (2009) for a comprehensive review of the mixed logit model and 
other advanced discrete choice methods using simulation.  
 An alternative to assuming that the coefficient distribution is continuous (e.g. normal or 
log-normal) is to specify that it is discrete. A mixed logit model with a discrete coefficient 
distribution is often referred to as a latent class logit model (e.g. Greene and Hensher 2003, Hole 
2008). The latent class logit probability that respondent n makes a particular sequence of choices 
is given by:  
0 1 2
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 (3.11) 
where the coefficients are given a class (c) subscript to indicate that preferences vary across (but 
not within) classes. ncH  is the probability that individual n belongs to class c, which is typically 

















where Zn is a vector of characteristics relating to individual n and γC is normalised to zero for 
identification purposes. Stata implementations of the mixed and latent class logit models are 
described in Hole (2007) and Pacifico and Yoo (2013). 
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Table 2. Example DCE question. 
Introductory text as in the CVM example 
Assume that a government authority is considering introducing one of the following two 
stricter water sanitation policies that will reduce the occurrence of campylobacter. 
 
Which option do you prefer 
 Policy A       
  Policy B                  
  None of the suggested policies (today’s situation remains and no additional cost for you) 
 Policy A Policy B 
Number of fewer individuals who die 
when the policy is implemented 
 
1 2 
Your cost 1 000 SEK 2 000 SEK 
 
Examples of Applications  
Using Hedonic Price Regressions to Value Mortality Risks 
To provide an example of a hedonic pricing study valuing mortality risks, we describe a study by 
Gentry and Viscusi (2016) where they specified the basic hedonic regression equation as (Gentry 
and Viscusi 2016, p.93): 
α  (4.1) 
The equation shows that the natural logarithm of wage (w) for an individual i in industry j and 
occupation k was regressed on a set of individual demographic controls (X) such as age, sex, 
race, years of education etc., a set of industry- and occupation-specific controls (W), the fatality 
(p) and injury (q) rate. The coefficient estimate of interest to value the mortality risk is , 
whereas  shows the impact on wage of the non-fatal injury rate. Data on wages and control 
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variables were collected on the individual level from the Current Population Survey (CPS), 
whereas the fatality and injury rate data were based on average risks per industry and occupation 
retrieved from the US Bureau of Labor Statistics (BLS) Census of Fatal Occupational Injuries.  
 The fatality rate is based on average industry-occupation risks and is calculated as: 
 (4.3) 
where N is the number of fatal injuries and EH is total hours worked by everyone in the specific 
industry-occupation group. The rate is multiplied by 2,000 (hours worked per year per worker) 
and subsequently by 100,000 to express the rate as the annual risk per 100,000 people. The 
reported overall annual fatality rate was 6.23 fatalities per 100,000 employees, but this varied 
from e.g. 0.75 fatalities per 100,000 health care employees to 70.1 fatalities per 100,000 
employees in forestry, fishing and hunting occupations. The injury rate is calculated in a similar 
manner, with the difference that N is the number of work days lost due to injury per year. 
 The results from estimating Eq. (4.1) showed that a higher fatality and injury rate were 
both statistically significantly related to lower hourly wages. An increase in the fatality rate by 1 
in 100,000 was associated with a 0.16% higher hourly wage. Hence, the evidence suggest that 
workers are compensated to take on risk, and based on Eq. (4.1) the VSL was estimated as: 
 (4.3) 
where the mean hourly wage ( ) is multiplied by 2,000 to convert the hourly wage into an 
annual wage. The annual wage is then multiplied by 100,000 to take into account that the risk is 
per 100,000 workers. Based on the regression result and the mean wage for the full sample, the 
implicit VSL was estimated at $5.36 million.vi  
 There has been a large number of similar studies carried out using wage-risk equations to 
estimate the implicit VSL. Viscusi (2014) reviewed many of the wage-risk studies and updated 
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to $2016 (based on the GDP deflator) the mean predicted VSL ranged from $7.5 million to $10.3 
million in the US sample. Results from this literature has been important in policy making by 
influencing the recommended VSL estimates for economic evaluations especially in the US, by 
e.g. the US Department of Transport and the US Environmental Protection Agency (EPA 2010, 
DoT 2016). 
 
Using Stated Preferences to Value Mortality Risks 
Since SP methods can be tailor-made to value any specific condition they have been applied to a 
broader range of health risks than the RP method. For example, SP methods have been used to 
estimate the WTP for primary care cancer tests, insecticide treated mosquito nets to reduce 
malaria risks, and for genetic testing for inherited retinal disease (Biadgilign et al. 2015, Tubeuf 
et al. 2015, Hollinghurst et al. 2016). However, the single largest area of study has been to 
estimate the WTP to reduce mortality risks, i.e. comparable to the case with hedonic price 
regressions. A recent meta-analysis covering only a sub-set of all VSL estimates (Lindhjelm et 
al. 2011) includes almost 1,000 published VSL estimates using SP methods. Here we borrow 
from two SP studies to provide examples from this literature. 
 
A CVM Application 
Hammitt and Haninger (2017) use the CVM method to estimate the WTP for small reductions in 
the risk of suffering non-fatal health conditions. The survey was administered to a sample drawn 
randomly from a US internet panel. The survey respondents were asked to choose whether they 
would participate in a health protection program that would reduce the risk of developing a 
particular illness from exposure to environmental contaminants. The illness varied across survey 
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versions and was described using the EQ-5D health-state descriptive system (EuroQol group 
1990). In addition, half of the respondents were presented with the condition name (e.g. 
“Migraine headaches”). Depending on the question, the risk reduction either related to the 
respondent themselves, another adult living in the household or a child younger than 18 years. 
The baseline mortality risks and risk reductions used in the survey are shown in Table 3.  
 
Table 3. Mortality risks and risk reductions in Hammitt and Haninger (2017) 




3 in 10,000 2 in 10,000 1 in 10,000 
3 in 10,000 
4 in 10,000       
4 in 10,000 
1 in 10,000 
3 in 10,000 
2 in 10,000 
2 in 10,000 
1 in 10,000 
2 in 10,000 
Note: All figures are per year.  
 
The baseline, reduction and final risk were presented using a grid containing 10,000 squares, 
with the number of red squares corresponding to the risk after reduction (1, 2 or 3) and the 
number of white squares to the risk reduction (1 or 2). The total number of red and white squares 
represented the baseline risk (3 or 4). The risk information was also presented numerically, as in 
Table 3.  
 The WTP elicitation format was double-bounded dichotomous choice, in which 
respondents are asked two sequential closed-ended CVM questions in each valuation task. The 
respondents were first asked if they would be willing to pay a cost $X to participate in the 
program, where X ranged from $10 to $2,000 per year. If they answered yes (no) to the initial 
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WTP question, a second question followed where they were asked if they would participate in 
the program if the cost was $X 2 ($X 0.5). To set the range of the initial cost (bid) vector the 
authors assessed the implicit minimum and maximum value per statistical illness covered. With a 
range from $10 to $2,000 this value ranges from <$50,000 (which results from not paying $10 
for the 2/10,000 risk reduction) to >$20 million (resulting from being willing to pay $2000 for 
the 1/10,000 risk reduction).  
 The authors estimated the following model using interval regression: 
 ( )* 1 2 3ln ln( ) ln( ) ln( )i i i i i iWTP r q t Xα γ γ γ β ε′= + + + + +                                      (4.3) 
where ri is the reduction in the probability of illness, qi is the reduction in health-related quality 
of life (HRQL) as a result of the illness (on a scale from 0 to 1) and ti is the duration of the 
illness. The vector Xi includes additional control variables, such as current HRQL, and εi is a 
normally distributed error term. This model specification implies that 1γ  is the elasticity of WTP 
with respect to a change in the probability of illness. The standard theory implies that for small 
changes in the probability this elasticity should be close to 1, implying that WTP is near-
proportional to small changes in risk. 
 The authors estimated the model in Eq. (4.3) on four different samples: including all 
responses or including only responses in which the target of the risk reduction was the 
respondent, another adult living in the household or a child younger than 18 years.  In all four 
samples the coefficient on the reduction in the probability of illness was found to be close to (and 
insignificantly different from) 1, confirming the theoretical prediction that WTP is near-
proportional to small changes in risk. The coefficients on the reduction in health-related quality 
of life and the duration of the illness were found to be positive, but less than 1, indicating that the 
WTP increases with these variables but not proportionally. Including dummy variables for the 
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target type in the pooled model indicated that the respondents have a higher WTP for reducing 
the probability of illness for a child younger than 18 years (200% more) and another adult living 
in the household (150% more) than for themselves. The authors carried out various sensitivity 
analyses, which generally did not affect the main findings. 
 The modelling results can be used to estimate the WTP for different illnesses 
characterized by their duration and reduction in health related quality of life. The predicted WTP 
for a statistical illness can be calculated by predicting log(WTP) using the regression results, 
exponentiating the predicted value (which yields an estimate of median WTP) and dividing by 
the risk reduction. Some illustrative values are presented in table 4:vii 
 
Table 4. Values per statistical illness (in dollars) 
Duration(years) HRQL loss Household member at risk 
  Self Child Other adult 
1 0.1 678,000 2,010,000 1,670,000 
1 0.8 1,380,000 4,090,000 3,400,000 
5 0.1 817,000 2,420,000 2,020,000 
5 0.8 1,660,000 4,930,000 4,100,000 
 
It can be seen from the table that the predicted WTP for children in the household is about 3 
times as high as the value for the respondents themselves, while the WTP for another adult is 
about 2.5 times as high. This corresponds to the magnitudes of the estimated target type dummy 
coefficients. It is also apparent that while the WTP increases in the HRQL loss the increase is not 
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proportional (the WTP of a 0.8 decrease in HRQL is less than 8 times the WTP of a 0.1 
decrease), which is a result of the HRQL coefficient being positive but less than one.         
 
A Discrete Choice Experiment Application 
Adamowicz et al. (2011) used the DCE method to elicit consumers’ preferences for reductions in 
health risks associated with tap water. A sample drawn from a panel of Canadian internet users 
was invited by email to complete an online survey, which presented the respondents with 
information about the health risks and different programs to reduce such risks before introducing 
the DCE choice tasks. In the DCE the tap water delivered to households was described in terms 
of the following attributes: two types of mortality risks (cancer and microbial), two types of 
morbidity risks (cancer and microbial) and the costs to the household of disinfection and 
treatment methods to reduce the health risks. The respondents were presented with four DCE 




Table 5. Example DCE choice task from Adamowicz et al. (2011) 
This is the first scenario we want you to vote on. 










Get sick from 
microbial illness in 
a 35-year period 
23,000 15,000 7,500 
Die from microbial 
illness in a 35-year 
period 
15 10 5 
Get sick from 
bladder cancer in a 
35-year period 
100 50 100 
Die from bladder 
cancer in a 35-year 
period 
20 10 20 
Change to your 
water bill starting 
in January, 2005 
No change 
Increase $75 per 
year ($6.25 per 
month) 
Increase $75 per 
year ($6.25 per 
month) 
 
If there was a referendum I would vote for… 
CHECK ONE ONLY 
  Current Situation       
   Proposed Program A 
   Proposed Program B                  
Note: the choice sets used in the actual survey also included a graphical representation of the 
mortality and morbidity risk attributes. 
 
 
The respondents’ utility function was specified to be a linear function of the attributes, i.e. the 
number of microbial deaths and illnesses averted ( ,njt njtmdie msick ), the number of cancer deaths 
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and illnesses averted ( ,njt njtcdie csick ) and the cost of the program ( njtcost ), as well as a status 
quo dummy variable   ( njtsq ) and an error term ( njtε ):    
0 1 2 3 4 5njt njt njt njt njt njt njt njtU sq mdie msick cdie csick costβ β β β β β ε= + + + + + +  (4.3) 
The authors estimated the parameters in the utility function using an MNL model with and 
without interactions between the status-quo variable and respondent characteristics. Evidence of 
preference heterogeneity was explored by using a mixed logit model with lognormally 
distributed mortality and morbidity risk coefficients and a fixed (non-random) cost coefficient, 
and a latent class logit model with two classes in which the class membership was modelled as a 
function of individual characteristics.  
 Based on the results from the MNL model the authors found that the WTP for one fewer 
microbial death in the community was $12.6, while the WTP for one fewer cancer death was 
$10.4 (including respondent characteristics in the model made little difference to the results).ix 
The difference between these MWTP estimates was not found to be statistically significant. The 
difference between the MWTP estimates for morbidity risk reductions, on the other hand, was 
found to be statistically significant, with cancer risk reductions being valued more highly ($2.43 
vs $0.02). The corresponding mean MWTP estimates from the mixed and latent class logit 
models are $15.0/$13.6 (microbial mortality risk), $10.8/$12.2 (cancer mortality risk), 
$0.02/$0.02 (microbial morbidity risk) and $3.05/$2.32 (cancer morbidity risk).  
 While the mean MWTP estimates were found to be similar across models, there is 
evidence of a large degree of preference heterogeneity among respondents. The results from the 
latent class model suggest that there are two distinct groups of respondents, one of which is 
reluctant to move away from the status quo and show an unwillingness to make tradeoffs for 
improved water quality. The authors argue that this suggests that a discrete representation of 
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preference heterogeneity is appropriate in this context since it allows such behavior to be 
identified, while a continuous representation of preference heterogeneity (as in the mixed logit 
model) does not. 
 The VSL was found to be $17 million for microbial death and $14 million for cancer 
death according to the MNL model. The VSL estimates are derived by multiplying the MWTP 
estimates by the number of households in the community (38,500) over a 35-year period.x The 
estimates are in the high end of the range reported in the VSL literature, which the authors 
suggest may be due to the fact that their estimates are based on the WTP to reduce public 
mortality risks. This means that they include both the WTP to reduce the risk of death to oneself 
as well as the WTP to reduce risk of death to others in the community, including family 
members. This contrasts to the majority of studies in the VSL literature, which estimate the value 
of private mortality risk reductions.    
 
Discussion 
We have provided an overview of the valuation of health risks as carried out in economics. The 
WTP approach is well established as the appropriate approach to assign monetary values to 
health risks that reflect individual preferences. As described in section 2, the monetizing of 
health risks is based on well-developed theoretical models that provide predictions for the 
empirical applications of the WTP approach. Among economists, the valuation of health is quite 
uncontroversial; individuals make daily decisions in their lives that suggest that they have a finite 
WTP to reduce their risk of fatality, injury, illness, etc. Moreover, when health policies are 
implemented it is not known who will benefit from the policies, only that a certain number of 
deaths, injuries, etc. will be prevented (veil of ignorance). However, among non-economists it is 
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controversial to assign monetary values to health outcomes, especially to the “value of life”. This 
means that the values obtained in empirical studies are often heavily scrutinized, whether from 
RP or SP studies, simply because they are considered to “price” health outcomes. Advocates of 
WTP studies for health outcomes obviously do not agree with the ethical objections to valuing 
health, but can agree on the fact that analysts face several difficulties when implementing health 
valuation studies. 
 Economists have traditionally been more willing to accept estimates from RP methods 
considering the reliance on actual behavior. A drawback with the RP approach is that markets do 
not always exist for the good of interest. For example, it may be that individuals have different 
preferences for different kinds of risks, such as the risk of dying from cancer versus the risk of a 
fatal workplace accident. Furthermore, the hedonic wage method depends crucially on the 
analyst having access to accurate measures of risk as well as all relevant individual and job-
related characteristics, in order to avoid biases arising from either measurement error or omitted 
variables.  
 There is a larger literature focusing on the limitations and drawbacks of SP methods (see 
e.g. Hausman 2012). The main criticism of SP methods is that decisions are hypothetical, which 
means that respondents do not have incentives to be well informed when making their decision 
and that their stated response may not reveal how they would act if the decision had been real. A 
particular issue that has received much attention in the literature is the lack of sensitivity to 
scope. While most CVM studies find evidence that the WTP for risk reductions is increasing 
with the size of the reduction in risk, the increase is typically not near-proportional, which is a 
necessary validity criterion for SP-based WTP estimates (Hammitt and Graham 1999, Corso et 
al. 2001, Robinson and Hammitt 2015). Although there is less evidence on scope sensitivity in 
 35
DCEs, especially using between-subject designs in which different respondents are presented 
with different risk reductions, recent findings suggest a lack of scope sensitivity in DCEs as well 
(Andersson et al. 2016).xi This evidence implies that SP estimates of the WTP for risk reductions 
must be interpreted with caution. However, despite the criticism of eliciting preferences based on 
hypothetical scenarios there has been a large increase in the use of SP studies over the past few 
decades (Carson and Hanemann 2005).  
 Despite criticism and shortcomings of both the RP approach, e.g. non-existing markets 
and that the analysts may not be well informed about the decision alternatives individuals do 
face, and of the SP approach, as listed above, both approaches have a key role to play in eliciting 
preferences for health risk reductions. Since no easily available prices are available for health 
risk reductions non-market valuation methods are necessary to monetize these preferences. There 
has also been a lot of progress in estimating WTP for health risk reductions over the last couple 
of decades, both regarding access to data for RP studies, and methodological improvements in 
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Notes 
                                                
i There is a very large literature on CEA and health risk metrics used in CEA, such as Quality Adjusted Life Years (QALYs) and 
Disability Adjusted Life Years (DALYs). These methods and metrics will not be covered in this paper, which has a focus on the 
welfare economics approach to health risk valuation. 
ii
 Such a large variation in possible health outcomes, and context dependence related to survival when presenting the theoretical 
model 
iii Other versions of the CVM method, such as the use of payment cards, have also been used in practice, although the open and 
closed-ended approaches are the most commonly used.  
iv If the respondents are presented with a single bid the observations are either left- or right-censored in the interval regression 
terminology. If respondents are additionally presented with a follow-up bid then some observations will be intervals (if the 
respondent accepts one bid and rejects the other), left censored (if both bids are rejected) or right censored (if both bids are 
accepted).  
v A multinomial logit model with alternative-specific attributes is often referred to as a conditional logit model (see e.g. Lancsar 
et al. (2017) 
 43
                                                                                                                                                           
vi The authors also extend the basic model to incorporate what they call morbidity risks associated with a fatal injury, which 
captures the number of days from the injury until death. For example, some deaths occur immediately after an injury, whereas in 
other cases the time from injury to death (when it occurs) may stretch up to several months. 
vii
 We refer interested readers to Hammitt and Haninger (2017) for information on the values chosen for the different explanatory 
variables when generating the predicted values of log(WTP). 
viii Some respondents were instead randomly chosen to complete DCE tasks with only two alternatives (one program and the 
current situation) and DCE tasks in which the ratio of morbidity and mortality reductions were held constant. The survey also 
included three double-bounded CVM choice tasks, but here we focus on the DCE results. 
ix The MWTP estimates are calculated as the ratios between the mortality risk and cost coefficients as exemplified in equation 
3.8. 
x The calculations assume that the risk of death is equally likely over the entire 35-year period. The authors also present a 
sensitivity analysis in which this assumption is relaxed. 
xi Between-subject designs are considered a more stringent approach to test for scope sensitivity, as within-subject designs may 
lead to a failure to reject scope sensitivity due to respondents’ desire to be ‘internally consistent’ when completing the survey. 
